Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII - clarification of Kogenate inhibitor data - Response

被引：0
作者：
Gringeri, A [1 ]
机构：
[1] Mangiagalli & Regina Elena Hosp Fdn, IRCCS Maggiore, A Bianchi Bonomi Haemophilia & Thrombosis Ctr, Milan, Italy
[2] Univ Milan, Milan, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2005年 / 130卷 / 01期
关键词：
B-domain-deleted FVIII; haemophilia A; inhibitors; recombinant FVIII;
D O I：
10.1111/j.1365-2141.2005.05552.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：146 / 147
页数：3
相关论文
共 5 条
  • [1] Abshire TC, 2000, THROMB HAEMOSTASIS, V83, P811
  • [2] AygorenPursun E, 1997, THROMB HAEMOSTASIS, V78, P1352
  • [3] Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII
    Gringeri, A
    Tagliaferri, A
    Tagariello, G
    Morfini, M
    Santagostino, E
    Mannucci, P
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) : 398 - 404
  • [4] European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients
    Rothschild, C
    Scharrer, I
    Brackmann, HH
    Stieltjes, N
    Vicariot, M
    Torchet, MF
    Effenberger, W
    [J]. HAEMOPHILIA, 2002, 8 : 10 - 14
  • [5] The epidemiology of inhibitors in haemophilia A: a systematic review
    Wight, J
    Paisley, S
    [J]. HAEMOPHILIA, 2003, 9 (04) : 418 - 435
1